(Q44895107)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15142051%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Outcome of lamivudine resistant hepatitis B virus mutant post-liver transplantation on lamivudine monoprophylaxis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15142051%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

main subject

liver transplantation

1 reference

1 reference

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15142051%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Joseph Sung

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15142051%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1

Henry Lik-Yuen Chan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15142051%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Alex Yui Hui

5

object named as

Alex Yui Hui

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15142051%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Albert Ka-Keung Chui

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15142051%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Wan-Yee Lau

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15142051%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Francis Ka-Leung Chan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15142051%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Araga Ramesha Nitin Rao

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15142051%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

John Wong

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15142051%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 June 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15142051%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

published in

Clinical Transplantation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15142051%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15142051%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15142051%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

295-300

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15142051%20AND%20SRC:MED&resulttype=core&format=json

Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00163.X

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00163.X

A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00163.X

Liver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00163.X

Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00163.X

Outcome of lamivudine resistant hepatitis B virus infection in liver transplant recipients in Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00163.X

Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00163.X

Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00163.X

Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00163.X

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00163.X

Viral load is a significant prognostic factor for hepatitis B virus-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00163.X

Hepatitis B e antigen and the risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00163.X

Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00163.X

Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00163.X

Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00163.X

Successful treatment with adefovir dipivoxil in a patient with fibrosing cholestatic hepatitis and lamivudine resistant hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00163.X

Acute liver graft failure due to emergence of lamivudine resistant hepatitis B virus: rapid resolution during treatment with adefovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00163.X

Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00163.X

Liver transplantation in European patients with the hepatitis B surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00163.X

Lamivudine as initial treatment for chronic hepatitis B in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00163.X

Lamivudine for hepatitis B in liver transplantation: a single-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2004.00163.X

10.1111/J.1399-0012.2004.00163.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15142051%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference